Antares Therapeutics

Antares Therapeutics is at the forefront of transforming patient lives through pioneering precision medicine, driven by a unique scientific approach and an unwavering commitment to innovation. Born from the advanced capabilities of Scorpion Therapeutics, the company challenges existing boundaries in drug discovery to create transformational therapies. Their integrated teams utilize specialized methods across medicinal chemistry, target biology, and predictive sciences to unlock previously undrugable targets, facilitating the development of novel treatments.

Antares focuses on first-in-class and validated targets using state-of-the-art technologies, including advanced machine learning and proprietary algorithms. This innovative strategy allows them to identify unique disease vulnerabilities and optimize new drug candidates tailored to specific patient populations. Collaborating with partners like AstraZeneca and Pierre Fabre Laboratories, Antares aims to revolutionize therapy for cancers and other serious diseases. Their pipeline includes pioneering small molecule assets, with promising candidates expected to enter clinical trials in the near future. With a robust leadership team, Antares is poised to bring meaningful advancements in patient care.